Komori
Other Disclosures5242EYEZ,INC.Information and Communications, Services and Others

アイズ Obtains “YMAA” Gold Organization Certification, Strengthening Its Advertising Operations Framework to Comply with the Pharmaceutical and Medical Device Act and Medical Advertising Guidelines

EYEZ,INC. obtained YMAA Gold Organization Certification as an advertising agency compliant with the Pharmaceuticals and Medical Devices Act and the Medical Advertising Guidelines. The company said that obtaining the certification strengthened its internal knowledge and operational framework for advertising management.

Worth reading
49Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Improvement
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Definitive
How definitive the wording is.

Announced details

YMAA (Pharmaceuticals and Medical Devices Act and Medical Care Act-Compliant Advertising Agency Certification)Word-of-mouth marketing service 「トラミー」COSME bi (cosmetics service)
Applicable field (uses covered by this announcement)

Advertising operations compliant with the Pharmaceuticals and Medical Devices Act and the Medical Advertising Guidelines

Launch dateAlready obtained as of the announcement on 17 August 2026
What the company reported numerically
Usage history

Approximately 150,000 Trammy members (as of July 2026)

Relationship between the counterparty and the company
EYEZ,INC.5242
Relationship with the Company

EYEZ,INC. obtained the YMAA Gold Organization Certification accredited by the association. Capital, personnel, and ordinary business relationships: Not disclosed.

Counterparty一般社団法人薬機法医療法規格協会

A general incorporated association that accredits a certification system for advertising personnel responsible for matters concerning the Pharmaceuticals and Medical Devices Act and the Medical Advertising Guidelines. Location, representative, capital, and year established: Not disclosed.

Award/certification name

YMAA (Pharmaceuticals and Medical Devices Act and Medical Care Act-Compliant Advertising Agency Certification) Gold Organization Certification

Awarding / certifying body

一般社団法人薬機法医療法規格協会

Location (as indicated in this announcement)

7F Shibuya Prestige, 3-12-22 Shibuya, Shibuya-ku, Tokyo

In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.

Source (materials cited by the company)

Official website of 一般社団法人薬機法医療法規格協会 (YMAA organization certification overview); Tokyo Shoko Research, Ltd. (September 2025 survey identifying the service as No. 1 in Japan)

Announced details
ItemDetails
Names of Products / Services CoveredYMAA (Pharmaceuticals and Medical Devices Act and Medical Care Act-Compliant Advertising Agency Certification), Word-of-mouth marketing service 「トラミー」, COSME bi (cosmetics service)
Counterparty一般社団法人薬機法医療法規格協会
Counterparty overviewA general incorporated association that accredits a certification system for advertising personnel responsible for matters concerning the Pharmaceuticals and Medical Devices Act and the Medical Advertising Guidelines. Location, representative, capital, and year established: Not disclosed.
Relationship with the CompanyEYEZ,INC. obtained the YMAA Gold Organization Certification accredited by the association. Capital, personnel, and ordinary business relationships: Not disclosed.
Launch dateAlready obtained as of the announcement on 17 August 2026
Applicable areaAdvertising operations compliant with the Pharmaceuticals and Medical Devices Act and the Medical Advertising Guidelines
Award/certification nameYMAA (Pharmaceuticals and Medical Devices Act and Medical Care Act-Compliant Advertising Agency Certification) Gold Organization Certification
Awarding / certifying body一般社団法人薬機法医療法規格協会
Location7F Shibuya Prestige, 3-12-22 Shibuya, Shibuya-ku, Tokyo
Usage historyApproximately 150,000 Trammy members (as of July 2026)
SourceOfficial website of 一般社団法人薬機法医療法規格協会 (YMAA organization certification overview); Tokyo Shoko Research, Ltd. (September 2025 survey identifying the service as No. 1 in Japan)
Items this document does not state (7)
Contract ValueOffering priceContract DateRegistration number and expiry dateLocation scaleQuantitative EffectsImpact on Business Performance

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To improve knowledge of the Pharmaceuticals and Medical Devices Act and the Medical Advertising Guidelines and strengthen a more appropriate advertising operations framework.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
アイズ Obtains “YMAA” Gold Organization Certification, Strengthening Its Advertising Operations Framework to Comply with the Pharmaceutical and Medical Device Act and Medical Advertising Guidelines | EYEZ,INC. (5242) timely disclosure | Komori